Guthrie's Pharmaceutical Manufacturing Bill Passes the House

Press Release

Congressman Brett Guthrie's (KY-02) National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act passed in the U.S. House of Representatives. This bill encourages innovative pharmaceutical manufacturing.

Guthrie, who serves as Republican Leader of the Energy and Commerce Committee's Health Subcommittee, helped introduce this bipartisan bill with Energy and Commerce Committee Chairman Frank Pallone, Jr. (D-NJ).

"We need to ensure that we have next generation pharmaceutical manufacturing in the U.S. to produce treatments for current and future health care needs. Increased adoption of these technologies could open the door to a more robust U.S. manufacturing base, lower production costs, and a more secure drug supply chain. This legislation will help move us in the right direction by fostering innovations in pharmaceutical manufacturing technologies," said Guthrie.

The National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act gives the Food and Drug Administration (FDA) the ability to provide grants to institutions of higher education to foster innovations in these manufacturing technologies. The FDA would be able to designate institutions as National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing.

Continuous manufacturing technology produces prescription drugs in a continuous stream and is more efficient than "batch" manufacturing techniques. This technology makes it easier to increase production, control product quality, and produce multiple doses and strengths of drugs. Investing in advanced and continuous technologies in the United States can strengthen domestic supply chains, create jobs, and help decrease our dependency on the Chinese Communist Party for medications.

Source